Skip to the page

Data / Drug companies / Gurunanda, LLC

Gurunanda, LLC: 12 products in the FDA NDC directory, labeler code 70708

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Gurunanda, LLC (labeler code 70708) lists 12 products in the FDA National Drug Code Directory, covering 8 finished drugs by generic name. By type: 12 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on September 1, 2025.

The request: Watch Gurunanda, LLC (FDA labeler code 70708): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
70708
Products in commercial distribution
12
Packages
19
Finished drugs by generic name
8
Prescription products
0
Over the counter products
12
Flagged as original packager
11 of 11 products that carry the flag
Started marketing in the last 12 months
0
Earliest marketing start
February 12, 2024
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs1083.3%
Other unapproved drugs216.7%

Products by type

TypeProductsShare
Over the counter drugs12100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Rinse325%
Mouthwash325%
Powder, for solution216.7%
Spray216.7%
Paste18.3%
Ointment18.3%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
GuruNanda Pain Relief70708-937OintmentOver the counter monograph drugsSeptember 1, 2025
GuruNanda Anticavity70708-927MouthwashOver the counter monograph drugsSeptember 1, 2025
GuruNanda Healthy Gums70708-926MouthwashOver the counter monograph drugsSeptember 1, 2025
GuruNanda Pain Relief70708-834SprayOver the counter monograph drugsSeptember 1, 2025
GuruNanda Sensitive70708-645PasteOver the counter monograph drugsSeptember 1, 2025
GuruNanda Anti-Cavity70708-890RinseOver the counter monograph drugsAugust 1, 2025
GuruNanda Anti-Gingivitis70708-012RinseOver the counter monograph drugsAugust 1, 2025
GuruNanda Oxyfusion70708-010MouthwashOver the counter monograph drugsAugust 1, 2025
GuruNanda Oral Pain Relief70708-011RinseOver the counter monograph drugsJuly 4, 2025
GuruNanda Pain Relief70708-101SprayOver the counter monograph drugsJuly 1, 2025
Gurunanda nasal saline70708-210Powder, for solutionOther unapproved drugsFebruary 12, 2024
Gurunanda nasal saline70708-110Powder, for solutionOther unapproved drugsFebruary 12, 2024

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.